K

Active Director Director DIN 09790066
DIN 09790066 First appointment May 2023 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Kalpana

Data last updated:

Kalpana is a Director at Exolent Pharmaceuticals Private Limited (since 2023). The company operates in Food And Beverages. Exolent Pharmaceuticals Private Limited reported revenue of ₹45.1 Lakh (FY 2025).

DIN 09790066
Primary Designation Director
Industry Food And Beverages
First Appointment 02 May 2023
Oldest Company Age 4 yrs
Largest company Exolent Pharmaceuticals Private Limited · ₹45.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 May 20232022₹45.1 Lakh (FY 2025)Active

Board colleagues of Kalpana

NameDINCompanyDesignation
Saurabh Vashisth09790065Exolent Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Exolent Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kalpana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalpana

Kalpana currently holds 1 directorship: Exolent Pharmaceuticals Private Limited (Director, since 02 May 2023, revenue ₹45.1 Lakh (FY 2025)).

Kalpana was first appointed on 02 May 2023 as Director at Exolent Pharmaceuticals Private Limited.

The current boards of Kalpana's companies include Saurabh Vashisth (Exolent Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available